Hatfield Linda A, Chang Karen, Bittle Marianne, Deluca Joanne, Polomano Rosemary C
University of Pennsylvania School of Nursing, Philadelphia, Pennsylvania 19104, USA.
Adv Neonatal Care. 2011 Apr;11(2):83-92; quiz 93-4. doi: 10.1097/ANC.0b013e318210d043.
The treatment of pain is an essential component of the clinical and ethical care of infants. Despite evidence-based practice consensus statements recommending that infants receive analgesia during minor painful procedures, numerous studies have shown that procedural pain remains poorly managed in this population. Oral sucrose administration has been associated with calming effects and reductions in observed pain behaviors with preterm and term infants aged up to 1 year. The objective of this integrative review is to synthesize findings from published randomized controlled trials evaluating the efficacy and safety of oral sucrose as a preprocedural intervention for mild to moderate procedural pain in infants. Overall, studies indicate that oral sucrose is an effective, safe, convenient, and immediate-acting analgesic for reducing crying time and significantly decreases biobehavioral pain response following painful procedures with infants.
疼痛治疗是婴儿临床护理和伦理关怀的重要组成部分。尽管有基于证据的实践共识声明建议婴儿在进行小的疼痛性操作时接受镇痛治疗,但大量研究表明,这一人群的程序性疼痛仍未得到妥善处理。口服蔗糖已被证明对1岁以下的早产和足月婴儿具有镇静作用,并能减少观察到的疼痛行为。本综合综述的目的是综合已发表的随机对照试验的结果,评估口服蔗糖作为婴儿轻度至中度程序性疼痛的术前干预措施的有效性和安全性。总体而言,研究表明口服蔗糖是一种有效、安全、方便且起效迅速的镇痛药,可减少哭闹时间,并显著降低婴儿在接受疼痛性操作后的生物行为疼痛反应。